📰 Paper Session News
Paper Session News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Paper Session. Real-time updates on events, politics, business and more.
January 8, 2024
GATE Chemical Engineering (CH) Previous Year Paper: Download GATE Chemical Engineering previous year question papers pdf for the past 10 years. All the candidates of GATE 2024 are advised to solve the GATE Chemical Engineering previous year's question paper to understand the structure and the difficulty level of the exam.
October 16, 2023
MARSEILLE, France, October 16, 2023--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that the following presentations will be presented at the European Society for Medical Oncology (ESMO) Congress 2023, taking place October 20-24 in Madrid, Spain.
October 16, 2023
Oral Presentation at ESMO will feature updated results from Phase 1/2 SPENCER studyPARIS, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Enterome, a clinical-stage company developing first-in-class immunomodulatory drugs for solid and liquid malignancies and inflammatory diseases based on its unique Mimicry platform, today announced that updated data from its Phase 1/2 SPENCER study on EO2401, in combination with nivolumab in patients with adrenal tumors, will be presented in an oral session at the European
October 12, 2023
The recently approved 8-mg dose of aflibercept has shown sustained improvement in vision and anatomical markers out to 96 weeks, according to updated clinical trial results.
October 6, 2023
Presentations Will Feature Data From ZETA-1 Phase 2 Trial of APX3330 in Diabetic RetinopathyFARMINGTON HILLS, Mich., Oct. 06, 2023 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing small-molecule therapies for the treatment of retinal and refractive eye disorders, today announced presentations featuring results from the ZETA-1 Phase 2 Trial of APX3330 at the 23rd Euretina Congress to take plac
September 7, 2022
Not intended for US- or Canada-based media Late-breaking data highlight 5-year survival results from Phase II study of the investigational IAP inhibitor xevinapant in the curative setting of unresected
September 7, 2022
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that data from studies of Verzenio® (abemaciclib) and Retevmo® (selpercatinib) will be...
May 4, 2022
At #AGS22, @AmerGeriatrics and #geriatrics experts casts a wide net for social & scientific innovations shaping better care for us all as we age. http://ow.ly/H6OV50IZluC.
April 27, 2022
27.04.2022 - OK-101 ameliorates neuropathic corneal pain in a mouse model of ciliary nerve ligation BAM8-22 peptide analog OK-201 alleviates neuropathic corneal pain in mice LONDON, April 27, 2022 (GLOBE NEWSWIRE) - OKYO Pharma Limited (LSE: OKYO; OTCQB: ... Seite 1
April 27, 2022
Investegate announcements from OKYO Pharma Limited, Upcoming Presentations at Ophthalmic Conference